Diet food brands have been hit in recent years, but now GLP-1 drugs like Ozempic are hitting the market, will this spell the ...

With three meds approved for weight management and several on the way, these may make a dent in the obesity epidemic.

Not long after the FDA wrapped its preliminary investigation of GLP-1 receptor agonists and suicidal thoughts or actions, the ...

A lean-looking Elon Musk revealed Wednesday that he uses Mounjaro — after previously expressing support for similar ...

The quest for effective weight loss solutions has never been more urgent, with millions of people worldwide struggling to ...

Glucagon-like peptide-1 receptor agonists (GLP-1 RA) significantly reduce the risk for clinically meaningful chronic kidney disease (CKD) progression and major adverse cardiovascular events (MACE) in ...

The analysis included five trials for DPP-4 inhibitors, eight for GLP-1 RAs, and 14 for SGLT2 inhibitors. The oldest trial was in 2013 and the most recent in 2023. The studies investigated ...